The sumoylation pathway is dysregulated in multiple myeloma and is associated with adverse patient outcome

Driscoll, J. J.; Pelluru, D.; Lefkimmiatis, K.; Fulciniti, M.; Prabhala, R. H.; Greipp, P. R.; Barlogie, B.; Tai, Y. -T.; Anderson, K. C.; Shaughnessy, Jr. J. D.; Annunziata, C. M.; Munshi, N. C.